Skip to main content
Premium Trial:

Request an Annual Quote

Technical Development Scientist, Genomics (Individualized Therapies)



Job Location

1 DNA Way
South San Francisco, CA 94080
United States


  • Medical, Dental, Vision (
  • Annual cash bonus
  • Annual equity bonus
  • New hire hire equity grant
  • 18 days vacation
  • Sabbatical program (additional 6 weeks off every 6 years)
  • 401k (4% dollar for dollar match plus 6% company contribution)
  • Bay Area shuttle/bus transporting 

Job Description

This position is part of Genentech's Pharma Individualized Medicines team responsible for the process development, manufacture and supply of individualized immunotherapies in collaboration with our global partners. The PTD-Genomics and Bioinformatics team uses high-throughput next generation sequencing (NGS) technologies to revolutionize production of these individualized therapies. 

We are seeking a highly motivated team member to contribute to the ongoing effort to operationalize the genomics components of individualized therapeutic manufacturing. You must have a broad working knowledge of molecular biology and NGS applications. The successful candidate is expected to effectively support ongoing clinical manufacturing, development and implementation of NGS assays. You will represent our team at cross-functional meetings and effective communication and developing collaborative relationships with key stakeholders will be an essential part of the role. 


  • Provide technical support for implementation of custom genomics processes within each Individualized Therapy  program. 
  • You will play a key role in technical development of NGS assays, related data analysis and authoring of technical reports to enable a new manufacturing paradigm and help deliver individualized immunotherapeutics to patients. 
  • Ensure alignment of genomics milestones with those of the broader team. Serve as the single point of contact to key stakeholders to execute on jointly defined deliverables, from project kick-off to method implementation.   




     The ideal candidate will meet the following qualifications: 

    • PhD in molecular biology, genomics, oncology or related fields with at least 2 years of experience working in diagnostics or pharmaceutical industry on NGS-based product or process development. 
    • 4+ years of hands-on experience working with Illumina based next generation sequencing workflows. In-depth knowledge of molecular techniques such as PCR, qRT-PCR, ddPCR, nucleic acid isolation and NGS sample prep technologies (WES, RNAseq, Target enrichment and single-cell sequencing). 
    • Demonstrated success in design, verification and validation of manual and automated NGS library preparation workflows with standard design control processes, documentation, QA/QC and regulatory requirements.
    • Experience with biostatistics, bioinformatics and/or data visualization is desirable.
    • Excellent technical writing skills with ability to author technical reports, protocols, SOPs for NGS-based assays.
    • Must be detail-oriented with strong project management and organizational skills in order to manage multiple projects and meet assigned deliverables. 
    • Ability to work well on teams and keep relevant stakeholders informed regarding the status of programs. 
    • Strong verbal communication skills and ability to effectively communicate and collaborate with cross-functional teams.
    • Comfortable working in a flexible, fast-paced team environment. 
    • Business travel up to 10% is anticipated for this role

    How to Apply

    • Requisition number 202105-114290

    Position link:


    About Our Organization

    At Roche, 94,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity, and diversity.  We believe every employee makes a difference. We are passionate about transforming patients’ lives. We are courageous in both decision and action, we believe that good business means a better world.

    Career Blog headlines

    Cycle Repeat?

    Nature News writes that some researchers are concerned that an infusion of funding for the National Institutes of Health could lead to another "boom and bust" cycle.

    Enrollment Down

    According to the Chronicle of Higher Education, enrollment at colleges and universities in the US was down this spring, as compared to 2020.

    The Pandemic and Women in STEM

    The New York Times reports on how the COVID-19 pandemic may affect women in STEM.

    Missing from the Top

    A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes.